Added to YB: 2026-02-06
Pitch date: 2026-02-04
IDXX [neutral]
IDEXX Laboratories, Inc.
-2.03%
current return
Author Info
No bio for this author
Company Info
IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally.
Market Cap
$50.0B
Pitch Price
$643.83
Price Target
N/A
Dividend
N/A
EV/EBITDA
33.73
P/E
47.87
EV/Sales
11.77
Sector
Health Care Equipment and Supplies
Category
growth
IDEXX Laboratories Q4 2025 Earnings Key Takeaways
IDXX (earnings): Q4 rev $1.09B (+14%), EPS $3.08 vs $2.93 est. FY25 rev $4.30B (+10%), EPS $13.08 (+14%). Record 1,900+ premium instrument placements, 69% organic growth in diagnostics instruments. 2026 guide: $4.63-4.72B rev (7-9% growth), $14.29-14.80 EPS (10-14% growth). Strong margins expanding 150bps, $1.1B FCF.
Read full article (2 min)